Phase 1 trial of CZ48 (camptothecin) capsules

Trial Profile

Phase 1 trial of CZ48 (camptothecin) capsules

Phase of Trial: Phase I

Latest Information Update: 11 Apr 2016

At a glance

  • Drugs Camptothecin (Primary)
  • Indications Cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 11 Apr 2016 Status changed from planning to recruiting, according to an NMT Pharmaceuticals media release.
    • 26 Nov 2013 This trial is expected to be initiated in the first quarter of 2014, and is expected to take 2 years to complete, according to a NanoMaterials Technology media release.
    • 26 Nov 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top